Patients with refractory reflux symptoms: What do they have and how should they be managed?

By  

NEUROGASTROENTEROLOGY & MOTILITY (ELECTRONIC), Vol. 27, Iss. 9, 2015-09 ,pp. : 1195-1201

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 41, Iss. 7, 2015-04 ,pp. : 649-661

John Wiley & Sons Inc

Access to resources Recommend Favorite

Do laryngoscopic findings reflect the characteristics of reflux in patients with laryngopharyngeal reflux?

By  

CLINICAL OTOLARYNGOLOGY, Vol. 43, Iss. 1, 2018-02 ,pp. : 137-143

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical relevance of esophageal and gastric pH measurements in patients with gastro-esophageal reflux disease (GERD)

By DiMarino Anthony J.   Cohen Sidney  

Current Medical Research and Opinion, Vol. 21, Iss. 1, 2005-01 ,pp. : 27-36

Informa Healthcare

Access to resources Recommend Favorite

Does the treatment of gastroesophageal reflux disease (GERD) meet patients' needs? A survey-based study

By Jones Roger   Armstrong David   Malfertheiner Peter   Ducrotté Philippe  

Current Medical Research and Opinion, Vol. 22, Iss. 4, 2006-04 ,pp. : 657-662

Informa Healthcare

Access to resources Recommend Favorite